TG Therapeutics NPS

TG Therapeutics's Net Promoter Score (NPS) is a -39 with 22% Promoters, 17% Passives, and 61% Detractors. Net Promoter Score tracks whether TG Therapeutics's customers would recommend using the product based on a scale of -100 to 100.

TG Therapeutics Overall NPS

-39

NPS

22%	Promoters
17%	Passives
61%	Detractors

TG Therapeutics NPS Trend

-100

-50

0

50

100

Summary	Date	Score
Mar 2022 -22	Mar 2022	-22
May 2022 -36	May 2022	-36
Sep 2022 -38	Sep 2022	-38
Oct 2022 -43	Oct 2022	-43
Jan 2023 -46	Jan 2023	-46
Apr 2023 -37	Apr 2023	-37
Dec 2023 -42	Dec 2023	-42
Mar 2024 -34	Mar 2024	-34
Feb 2025 -37	Feb 2025	-37
Mar 2025 -39	Mar 2025	-39
Apr 2025 -37	Apr 2025	-37
Aug 2025 -40	Aug 2025	-40

What is NPS

Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"

Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.